Hospira Mitoxantrone 25 mg/12.5 mL injection vial USP

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

mitoxantrone (mitozantrone) hydrochloride, Quantity: 2 mg/mL

から入手可能:

Hospira Australia Pty Ltd

INN（国際名）:

mitoxantrone (mitozantrone) hydrochloride

医薬品形態:

Injection

構図:

Excipient Ingredients: sodium chloride; water for injections; sodium acetate trihydrate; glacial acetic acid; sodium metabisulfite

投与経路:

Intravenous Infusion, Intraperitoneal

パッケージ内のユニット:

1 x 12.5 mL vial

クラス:

Medicine Listed (Export Only)

処方タイプ:

Not scheduled. Not considered by committee

適応症:

Mitoxantrone Injection, USP is indicated for chemotherapy in patients with: metastatic carcinoma of the breast, relapsed adult leukemia, lymphoma, and hepatoma. In combination with other drug(s), Mitoxantrone Injection, USP is indicated: in the initial therapy of acute non-lymphocytic leukemia (ANLL) in adults, including myelogenous, promyelocytic, monocytic and erythroid acute leukemias.

製品概要:

Visual Identification: A clear, dark blue solution; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store between 15-25 degrees Celsius

認証ステータス:

Listed (Export Only)

承認日:

2007-07-16